Bulletin
Investor Alert

Veracyte Inc.

NAS: VCYT

GO
/marketstate/country/us

After Hours

/zigman2/quotes/201957513/composite

$

36.51

Change

-0.96 -2.56%

Volume

Volume 33,416

Jun 18, 2021, 4:53 p.m.

Quotes are delayed by 20 min

/zigman2/quotes/201957513/composite

Previous close

$ 38.19

$ 37.47

Change

-0.72 -1.89%

Day low

Day high

$36.31

$38.52

Open
Open: 37.42

52 week low

52 week high

$22.87

$86.03

Open

Market cap

$2.52B

Average volume

797,205

P/E ratio

N/A

Rev. per Employee

$367,134

EPS

-1.09

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/vcyt

MarketWatch News on VCYT

  1. Veracyte initiated at outperform with $45 price target at Raymond James

    7:46 a.m. June 15, 2021

    - Tonya Garcia

  2. Veracyte stock price target cut to $55 from $84 at Truist

    7:33 a.m. May 18, 2021

    - Tomi Kilgore

  3. Veracyte stock price target cut to $54 from $88 at Needham

    6:49 a.m. May 11, 2021

    - Tomi Kilgore

  4. Veracyte started at buy with $61 stock price target at Truist

    8:43 a.m. Jan. 28, 2021

    - Tomi Kilgore

  5. Veracyte started at sector weight with $48 stock price target at KeyBanc Capital

    8:05 a.m. Nov. 10, 2020

    - Tomi Kilgore

  6. Veracyte downgraded to neutral from buy at Janney

    8:52 a.m. Nov. 7, 2017

    - Tomi Kilgore

  7. Veracyte upgraded to buy from neutral at Janney Montgomery Scott

    8:10 a.m. Nov. 29, 2016

    - Tomi Kilgore

Analyst Ratings

/news/nonmarketwatch/company/us/vcyt

Other News on VCYT

  1. Moving Average Crossover Alert: Veracyte (VCYT)

    7:18 a.m. June 9, 2021

    - Zacks.com

  2. Veracyte posts promising data from Percepta Genomic Atlas test

    12:56 p.m. May 14, 2021

    - Seeking Alpha

  3. Veracyte (VCYT) Reports Q1 Loss, Tops Revenue Estimates

    6:50 p.m. May 10, 2021

    - Zacks.com

  4. Veracyte names Marc Stapley CEO

    4:26 p.m. May 10, 2021

    - Seeking Alpha

  5. Veracyte CFO retires, expects Q1 prelim revenue growth of 17%

    4:18 p.m. April 15, 2021

    - Seeking Alpha

  6. Veracyte (VCYT) Investor Presentation - Slideshow

    6:37 p.m. April 8, 2021

    - Seeking Alpha

  7. 3 Cancer Diagnostic Monster Stocks on Sale

    6:12 a.m. April 3, 2021

    - Motley Fool

  8. Better Buy for the Next 10 Years: Abiomed vs. Guardant Heath

    6:57 a.m. April 1, 2021

    - Motley Fool

  9. Veracyte: Not Too Excited After Momentum Run

    7:42 a.m. March 1, 2021

    - Seeking Alpha

  10. 5 Stocks That Make Ark Innovation ETF (ARKK) Red Hot

    1:10 p.m. Feb. 18, 2021

    - Zacks.com

  11. Veracyte, Inc. 2020 Q4 - Results - Earnings Call Presentation

    7:23 p.m. Feb. 17, 2021

    - Seeking Alpha

  12. Veracyte (VCYT) Reports Q4 Loss, Tops Revenue Estimates

    6:25 p.m. Feb. 17, 2021

    - Zacks.com

  13. Veracyte secures $550M via equity raise

    12:52 a.m. Feb. 5, 2021

    - Seeking Alpha

  14. Veracyte to acquire Decipher Biosciences

    8:42 a.m. Feb. 3, 2021

    - Seeking Alpha

  15. Loading more headlines...
/news/pressrelease/company/us/vcyt

Press Releases on VCYT

  1. Veracyte to Present at Upcoming Investor Conferences

    3:00 p.m. June 2, 2021

    - BusinessWire - BZX

  2. Veracyte to Present at Upcoming Investor Conferences

    3:00 p.m. May 26, 2021

    - BusinessWire - BZX

  3. Veracyte to Present at Upcoming Investor Conferences

    5:15 p.m. May 18, 2021

    - BusinessWire - BZX

  4. Veracyte, Inc. Announces CEO Succession Plan

    4:10 p.m. May 10, 2021

    - BusinessWire - BZX

  5. Veracyte Announces First Quarter 2021 Financial Results

    4:05 p.m. May 10, 2021

    - BusinessWire - BZX

  6. Loading more headlines...

Rates »

Link to MarketWatch's Slice.